ZURICH, Sept 3 (Reuters) - U.S. regulators approved Novartis AG’s Omnitrope Pen 10 with liquid cartridge, a copy-cat version of Pfizer Inc’s human growth hormone Genotropin.
ZURICH, Sept 3 (Reuters) - U.S. regulators approved Novartis AG’s Omnitrope Pen 10 with liquid cartridge, a copy-cat version of Pfizer Inc’s human growth hormone Genotropin.